Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD

被引：1
|
作者：
Wang, Jian [1 ,2 ]
Pan, Yifan [3 ]
Xiong, Ye [4 ]
Wu, Chao [1 ,2 ]
Huang, Rui [1 ,2 ,4 ]
机构：
[1] Nanjing Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Dept Infect Dis,Med Sch, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China
[2] Nanjing Univ, Inst Viruses & Infect Dis, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Nanjing Drum Tower Hosp, Clin Coll, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China
[4] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2024年 / 60卷 / 07期
关键词：
D O I：
10.1111/apt.18176
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LINKED CONTENT This article is linked to McPherson et al papers. To view these articles, visit and
引用
收藏
页码：978 / 979
页数：2
相关论文
共 50 条
  • [1] Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply
    McPherson, Stuart
    Dyson, Jessica K.
    Jopson, Laura
    Masson, Steven
    Patel, Preya
    Anstee, Quentin M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (07) : 980 - 981
  • [2] Is liver fibrosis more advanced in MetALD than in MASLD?
    Fujii, Hideki
    Kamada, Yoshihiro
    Tokushige, Akihiro
    Watanabe, Toshio
    Kawada, Norifumi
    JOURNAL OF HEPATOLOGY, 2025, 82 (01) : e56 - e57
  • [3] Reply to: "Is liver fibrosis more advanced in MetALD than in MASLD?"
    Oh, Joo Hyun
    Jun, Dae Won
    JOURNAL OF HEPATOLOGY, 2025, 82 (01) : e58 - e59
  • [4] Age impacts the diagnostic ability of the enhanced liver fibrosis test for advanced fibrosis in MASLD
    Pekarska, Katrina
    Hinkson, Alexander
    Rowe, Ian
    Parker, Richard
    JOURNAL OF HEPATOLOGY, 2024, 80 : S534 - S534
  • [5] Letter: Using non-invasive fibrosis tests and emerging diagnostics to enhance the accuracy of liver fibrosis staging in MASLD patients
    Meng, Wenjun
    Yao, Ping
    Dan, Yuan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (01) : 212 - 213
  • [6] Limitations of Platelet Count as a Marker of Advanced Fibrosis in Patients With MASLD
    Ventura, Frank
    Bentley, Blake
    Ou, Jao
    Bundy, Jacob
    Obermmiller, Corey
    Rudnick, Sean
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1324 - S1324
  • [7] EXPLAINABLE ARTIFICIAL INTELLIGENCE ON PROTEOMICS FOR THE DIAGNOSIS OF ADVANCED LIVER FIBROSIS ON MASLD PATIENTS USING OPEN DATA
    Trifylli, Eleni Myrto
    Kriebardis, Anastasios
    Papadopoulos, Nikolaos
    Deutsch, Melanie
    Angelakis, Athanasios
    HEPATOLOGY, 2024, 80 : S628 - S629
  • [8] Accuracy of the recommended algorithm using Fib4 Score and fibroscan to identify MASLD patients with low risk for advanced liver fibrosis in "real world" practice
    Zuckerman, Inbal
    Azulay, Orly
    Zuckerman, Eli
    JOURNAL OF HEPATOLOGY, 2024, 80 : S548 - S548
  • [9] Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patients
    Compte, David Perez
    Etourneau, Lucas
    Hesse, Anne-Marie
    Kraut, Alexandra
    Barthelon, Justine
    Sturm, Nathalie
    Borges, Helene
    Biennier, Salome
    Courcon, Marie
    Loup, Marc de Saint
    Mignot, Victoria
    Costentin, Charlotte
    Burger, Thomas
    Coute, Yohann
    Bruley, Christophe
    Decaens, Thomas
    Jaquinod, Michel
    Boursier, Jerome
    Brun, Virginie
    BIOMARKER RESEARCH, 2024, 12 (01)
  • [10] Letter to the Editor: Development and validation of pFIB scores for exclusion of significant liver fibrosis in pediatric MASLD
    Zhang, Haowen
    Zhu, Xinyuan
    Zhou, Yunfeng
    Yuan, Yang
    HEPATOLOGY, 2024,
12345